Significant changes in the tau A0 and A3 alleles in progressive supranuclear palsy and improved genotyping by silver detection.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Archives of Neurology

• Publication date

  1998-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1001/ARCHNEUR.55.8.1122PMID 9708963
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic evidence for the involvement of τ in progressive supranuclear palsy

  1997cited by this paper
• Normal distribution of apolipoprotein E alleles in progressive supranuclear palsy

  1996cited by this paper
• Lack of association of apolipoprotein E epsilon 4 allele with progressive supranuclear palsy.

  1996cited by this paper
• High apolipoprotein E epsilon 4 allele frequency in age-related memory decline.

  1996cited by this paper
• Neurodegenerative disorders with extensive tau pathology: A comparative study and review

  1996cited by this paper
• Autopsy-proven progressive supranuclear palsy in two siblings

  1996cited by this paper
• High apolipoprotein E ε4 allele frequency in Age‐related memory decline

  1996cited by this paper
• Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)

  1996cited by this paper
• Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.

  1995cited by this paper
• Familial progressive supranuclear palsy. Description of a pedigree and review of the literature.

  1995cited by this paper
• Progressive supranuclear palsy: clinical and pathological diagnosis

  1995cited by this paper
• Apolipoprotein E4 allele frequency in Spanish Alzheimer and control cases.

  1995influential reference
• Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy)

  1994cited by this paper
• Progressive supranuclear palsy

  1994cited by this paper
• Clinical diagnosis and diagnostic criteria of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).

  1994cited by this paper
• Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

  1993cited by this paper
• Fast and sensitive silver staining of DNA in polyacrylamide gels.

  1991cited by this paper
• Tau protein and neurodegeneration

  1990cited by this paper

• Tau-Induced Pathology in Epilepsy and Dementia: Notions from Patients and Animal Models

  2018cites this paper
• Association of microtubule-associated protein tau gene polymorphisms with the risk of sporadic Alzheimer's disease: a meta-analysis

  2018cites this paper
• Update on the Diagnosis and Management of Progressive Supranuclear Palsy

  2016cites this paper
• Cellular minigene models for the study of allelic expression of the tau gene and its role in progressive supranuclear palsy

  2013cites this paper
• Progressive supranuclear palsy and corticobasal degeneration.

  2011cites this paper
• Genetic bases of Progressive Supranuclear Palsy: the MAPT tau disease.

  2011cites this paper
• Chapter 9 – Atypical parkinsonism, parkinsonism-plus syndromes, and secondary parkinsonian disorders

  2011cites this paper
• Familial aggregation in atypical Parkinson’s disease: a case control study in multiple system atrophy and progressive supranuclear palsy

  2010cites this paper
• Tau phosphorylation and aggregation as a therapeutic target in tauopathies.

  2010cites this paper
• Disentangling the role of the tau gene locus in sporadic tauopathies.

  2010cites this paper
• Rational therapeutic approaches to progressive supranuclear palsy.

  2010cites this paper
• Progressive Supranuclear Palsy

  2010cites this paper
• The effect of age and the H1c MAPT haplotype on MAPT expression in human brain.

  2009cites this paper
• 5'-Upstream variants of CRHR1 and MAPT genes associated with age at onset in progressive supranuclear palsy and cortical basal degeneration.

  2009cites this paper
• From 1997 to 2007: a decade journey through the H1 haplotype on 17q21 chromosome.

  2009cites this paper
• Genetics of progressive supranuclear palsy.

  2008cites this paper
• Functional MAPT haplotypes: bridging the gap between genotype and neuropathology.

  2007cites this paper
• Tauopathies: A Distinct Class of Neurodegenerative Diseases

  2007cites this paper
• The Tau N279K Exon 10 Splicing Mutation Recapitulates Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17 Tauopathy in a Mouse Model

  2007influential citation
• Progressive Supranuclear Palsy: Pathology and Genetics

  2007cites this paper
• ANÁLISIS DE GENES SITUADOS EN EL HAPLOTIPO H1 DE LA REGIÓN 17q21 Y DE GENES INVOLUCRADOS EN LA FOSFORILACIÓN DE TAU EN LA PARÁLISIS SUPRANUCLEAR PROGRESIVA

  2007cites this paper
• Tau protein in familial and sporadic diseases

  2007cites this paper
• Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms.

  2007cites this paper
• Identification of a Novel Risk Locus for Progressive Supranuclear Palsy by a Pooled Genomewide Scan of 500,288 Single-Nucleotide Polymorphisms

  2007cites this paper
• Association study of polymorphisms in LRP1, tau and 5-HTT genes and Alzheimer’s disease in a sample of Colombian patients

  2006cites this paper
• Untangling the tau gene association with neurodegenerative disorders.

  2006cites this paper
• A new mutation of the tau gene, G303V, in early-onset familial progressive supranuclear palsy.

  2005cites this paper
• High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy.

  2005cites this paper
• A New Mutation of the τ Gene, G303V, in Early-Onset Familial Progressive Supranuclear Palsy

  2005cites this paper
• Microtubule-associated protein tau gene: a risk factor in human neurodegenerative diseases.

  2004cites this paper
• Sequence analysis of tau 3'untranslated region and saitohin gene in sporadic progressive supranuclear palsy.

  2004cites this paper
• The role of tau (MAPT) in frontotemporal dementia and related tauopathies

  2004cites this paper
• Tau haplotype frequency in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

  2003cites this paper
• Dementia and genetics.

  2003cites this paper
• Further case of paroxysmal exercise‐induced dystonia and some insights into pathogenesis

  2002cites this paper
• Sequence analysis of tau in familial and sporadic progressive supranuclear palsy

  2002cites this paper
• Hemiballism after subthalamotomy in patients with Parkinson's disease: Report of 2 cases

  2002cites this paper
• Holmes' tremor and neuroparacoccidioidomycosis: A case report

  2002cites this paper
• Unilateral pallidal stimulation for segmental cervical and truncal dystonia: Which side?

  2002cites this paper
• Entacapone‐Induced Hepatotoxicity and Hepatic Dysfunction

  2002cites this paper
• Steele‐Richardson‐Olszewski syndrome in a patient with a single C212Y mutation in the parkin protein

  2002cites this paper
• Clozapine withdrawal symptoms in a Parkinson's disease patient

  2002cites this paper
• Tau, where are we now?

  2002cites this paper
• Hereditary chin trembling: A new family with exclusion of the chromosome 9q13‐q21 Locus

  2002cites this paper
• Oculo‐auricular phenomenon secondary to vestibular dysfunction

  2002cites this paper
• Progressive supranuclear palsy: clinical and genetic aspects

  2002cites this paper
• Further extension of the H1 haplotype associated with progressive supranuclear palsy

  2002cites this paper
• Polymorphisms in the tau gene in sporadic frontotemporal dementia and other neurodegenerative disorders

  2002influential citation
• Forty‐one year follow‐up of childhood‐onset opsoclonus‐myoclonus‐ataxia: Cerebellar atrophy, multiphasic relapses, and response to IVIG

  2002cites this paper
• Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy.

  2002cites this paper
• A polymorphism within intron 11 of the tau gene is not increased in frequency in patients with sporadic Alzheimer's disease, nor does it influence the extent of tau pathology in the brain.

  2002cites this paper
• Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson's disease

  2002cites this paper
• Association between the extended tau haplotype and frontotemporal dementia.

  2002cites this paper
• A genomic sequence analysis of the mouse and human microtubule-associated protein tau

  2001influential citation
• Tau and α-Synuclein in Neurodegenerative Diseases

  2001cites this paper
• Use and cost of outpatient visits of AD patients: CERAD XXII

  2001cites this paper
• Cortical Synapse Loss in Progressive Supranuclear Palsy

  2001cites this paper
• Progressive supranuclear palsy as a disease phenotype caused by the S305S tau gene mutation.

  2001cites this paper
• The extended haplotype of the microtubule associated protein tau gene is not associated with Pick's disease.

  2001cites this paper
• Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype

  2001cites this paper
• Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy

  2001cites this paper
• TAU as a susceptibility gene for amyotropic lateral sclerosis-parkinsonism dementia complex of Guam.

  2001cites this paper
• Progressive Supranuclear Palsy

  2001cites this paper
• An extended 5′-tau susceptibility haplotype in progressive supranuclear palsy

  2000cites this paper
• A novel presenilin 1 mutation (Leu166Arg) associated with early-onset Alzheimer disease.

  2000cites this paper
• Analysis of the polymorphic (GT)(n) repeat at the dopamine beta-hydroxylase gene in Spanish patients affected by schizophrenia.

  2000cites this paper
• Die neuropathologische Diagnostik neurodegenerativer und demenzieller Krankheiten

  2000cites this paper
• Tau pathology: a marker of neurodegenerative disorders

  2000cites this paper
• Tau protein isoforms, phosphorylation and role in neurodegenerative disorders.

  2000cites this paper
• Untangling tau-related dementia.

  2000cites this paper
• [Neuropathological diagnosis of neurodegenerative and dementia diseases].

  2000cites this paper
• Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations.

  2000cites this paper
• Tau polymorphisms are not associated with Alzheimer's disease.

  2000cites this paper
• Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease.

  2000cites this paper
• Progressive supranuclear palsy: earlier age of onset in patients with the τ protein A0/A0 genotype

  2000cites this paper
• Significant association between the tau gene A0/A0 genotype and Parkinson's disease

  2000cites this paper
• Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy

  2000cites this paper
• Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene

  2000cites this paper
• Molecular Mechanisms of Neurodegenerative Diseases

  2000influential citation
• REVIEW: tau protein pathology in Alzheimer’s disease and related disorders

  1999cites this paper
• Association of an extended haplotype in the tau gene with progressive supranuclear palsy.

  1999influential citation
• The tau gene A0 allele and progressive supranuclear palsy

  1999cites this paper
• What is new in degenerative dementia disorders?

  1999cites this paper
• Neurofibrillary tangle parkinsonian disorders—tau pathology and tau genetics

  1999cites this paper
• Recent advances in atypical parkinsonian disorders.

  1999cites this paper
• Identification of a novel polymorphism in the promoter region of the tau gene highly associated to progressive supranuclear palsy in humans.

  1999cites this paper
• FluoroDOPA PET shows the nondopaminergic as well as dopaminergic destinations of levodopa

  1999cites this paper
• Comparative Biochemistry of Tau in Progressive Supranuclear Palsy, Corticobasal Degeneration, FTDP‐17 and Pick's Disease

  1999cites this paper
• Mutational analysis of the tau gene in progressive supranuclear palsy.

  1999cites this paper
• OBSERVATION A New Mutation of the Gene , G 303 V , in Early-Onset Familial Progressive Supranuclear Palsy

  year unknowncites this paper